MALAT1 and lung carcinoma: For instance, lncRNA MALAT1 was identified as a potential prognostic biomarker in addition to the therapeutic target for people who are at an early stage of lung cancer because of its stability and specificity and this lncRNA showed the existence of a higher expression in nonsmall cell lung cancer tissues in comparison with the expression in adjacent tissues [25].